Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
COR is a health technology company that has developed a home-based blood analysis platform focused on metabolic health and personalized nutrition. The company's flagship product, the COR Console, utilizes near-infrared spectroscopy to analyze a small blood sample and provide immediate feedback on various health markers such as fibrinogen and cholesterol. By correlating blood data with dietary habits, COR offers users actionable insights to optimize their physical performance and long-term wellness. The company was founded by Bob Messerschmidt, a former Apple executive who contributed to the development of the Apple Watch's health sensors. COR's platform aims to bridge the gap between clinical diagnostics and daily lifestyle management, providing a data-driven approach to preventative health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on COR Health.